← boothcheck

Is ARX overvalued?

boothcheck doesn't label ARX overvalued or undervalued and publishes no house fair value, target price, or buy/sell rating. Individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. In the published model solve dated 2026-07-25T04:52:19.897Z, anchored at $14.24, the ARX price is not resolvable as a finite path at the model's stated assumptions: it sits beyond the tested range even at more than 40 years of ceiling-rate growth. Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium). The report narrative was composed 2026-07-25. The more the price assumes beyond what ACCELERANT HOLDINGS has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from ACCELERANT HOLDINGS's SEC EDGAR filings via a reverse-DCF inversion. Last analyzed July 25, 2026.

Model readbeyond tested growth range
Price vs asset value4.82x
Price vs peer multiples2.81x
Price vs forward growth1.24x
Read the full ARX report →
Get boothcheck's read on what ARX's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.